Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

被引：127

作者：

Lyke, Kirsten E. ^{[1
]}

Atmar, Robert L. ^{[2
]}

Islas, Clara Dominguez ^{[3
]}

Posavad, Christine M. ^{[3
,4
]}

Szydlo, Daniel ^{[5
]}

Chourdhury, Rahul Paul ^{[5
]}

Deming, Meagan E. ^{[1
]}

Eaton, Amanda ^{[6
]}

Jackson, Lisa A. ^{[7
]}

Branche, Angela R. ^{[8
]}

Sahly, Hana M. El ^{[2
]}

Rostad, Christina A. ^{[9
]}

Martin, Judith M. ^{[10
]}

Johnston, Christine ^{[3
,4
,11
]}

Rupp, Richard E. ^{[12
]}

Mulligan, Mark J. ^{[13
]}

Brady, Rebecca C. ^{[14
]}

Frenck, Robert W., Jr. ^{[14
]}

Backer, Martin ^{[15
]}

Kottkamp, Angelica C. ^{[13
]}

Babu, Tara M. ^{[11
]}

Rajakumar, Kumaravel ^{[10
]}

Edupuganti, Srilatha ^{[16
,17
]}

Dobrzynski, David ^{[8
]}

Coler, Rhea N. ^{[18
,19
]}

Archer, Janet I. ^{[20
]}

Crandon, Sonja ^{[21
]}

Zemanek, Jillian A. ^{[5
]}

Brown, Elizabeth R. ^{[3
]}

Neuzil, Kathleen M. ^{[1
]}

Stephens, David S. ^{[16
]}

Post, Diane J. ^{[21
]}

Nayak, Seema U. ^{[21
]}

Suthar, Mehul S. ^{[22
]}

Roberts, Paul C. ^{[21
]}

Beigel, John H. ^{[21
]}

Montefiori, David C. ^{[23
]}

DMID Std Grp

机构：

[1] Univ Maryland Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA

[2] Baylor Coll Med, Dept Med & Mol Virol & Microbiol, Houston, TX 77030 USA

[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA

[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Lab Med & Pathol, Seattle, WA USA

[5] Univ Washington, Stat Ctr HIV AIDS Res & Prevent SCHARP, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[6] Duke Univ Med Ctr, Dept Surg, Durham, NC USA

[7] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA

[8] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY USA

[9] Emory Univ Sch Med & Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Dept Pediat, Atlanta, GA USA

[10] Univ Pittsburgh Sch Med, Dept Pediat, Pittsburgh, PA USA

[11] Univ Washington, Dept Med, Seattle, WA USA

[12] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX USA

[13] NYU Langone Vaccine Ctr, NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA

[14] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA

[15] NYU Langone Hosp, Mineola, NY USA

[16] Emory Univ Sch Med, Dept Med, Atlanta, GA USA

[17] Hope Clin Emory Vaccine Ctr, Atlanta, GA USA

[18] Univ Washington Sch Med, Seattle Childrens Res Inst, Seattle, WA USA

[19] Univ Washington Sch Med, Dept Pediat, Seattle, WA USA

[20] FHI360, Durham, NC 27701 USA

[21] Natl Inst Allergy & Infect Dis, NIH, Div Microbiol & Infect Dis, Bethesda, MD USA

[22] Emory Univ, Atlanta, GA USA

[23] Duke Univ Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA

来源：

CELL REPORTS MEDICINE | 2022年 / 3卷 / 07期

基金：

美国国家卫生研究院;

关键词：

BA.2.12.1; BA.4/BA.5; booster; COVID-19; mRNA vaccine; neutralizing antibody; Omicron variant; recombinant adenovirus vaccine; SARS-CoV-2; sublineage;

D O I：

10.1016/j.xcrm.2022.100679

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to generate protective immunity. We assess the magnitude and short-term durability of neutralizing antibodies after homologous and heterologous boosting with mRNA and Ad26.COV2.S vaccines. All prime-boost combinations substantially increase the neutralization titers to Omicron, although the boosted titers decline rapidly within 2 months from the peak response compared with boosted titers against the prototypic D614G variant. Boosted Omicron neutralization titers are substantially higher for homologous mRNA vaccine boosting, and for heterologous mRNA and Ad26.COV2.S vaccine boosting, compared with homologous Ad26.COV2.S boosting. Homologous mRNA vaccine boosting generates nearly equivalent neutralizing activity against Omicron sublineages BA.1, BA.2, and BA.3 but modestly reduced neutralizing activity against BA.2.12.1 and BA.4/BA.5 compared with BA.1. These results have implications for boosting requirements to protect against Omicron and future variants of SARS-CoV-2.

引用

页数：13

共 50 条

[1] Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant
Parua, Pijus
Ghosh, Somnath
Jana, Koushik
Seth, Arnab
Debnath, Biplab
Rout, Saroj Kumar
Sarangi, Manoj Kumar
Dash, Rasmita
Halder, Jitu
Rajwar, Tushar Kanti
Pradhan, Deepak
Rai, Vineet Kumar
Dash, Priyanka
Das, Chandan
Kar, Biswakanth
Ghosh, Goutam
Rath, Goutam
CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (10) : 753 - 773
[2] Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
Chen, Lin-Lei
Chua, Gilbert T.
Lu, Lu
Chan, Brian Pui-Chun
Wong, Joshua Sung-Chih
Chow, Calvin Chit-Kwong
Yu, Tak-Ching
Leung, Agnes Sze-Yin
Lam, Shu-Yan
Wong, Tak-Wai
Tsang, Hing-Wai
Wong, Ian Chi-Kei
Chan, Kwok-Hung
Yuen, Kwok-Yung
Ip, Patrick
Kwan, Mike Yat-Wah
To, Kelvin Kai-Wang
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 543 - 547
[3] Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
Wang, Lidong
Mohlenberg, Michelle
Wang, Pengfei
Zhou, Hao
CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 70 : 13 - 25
[4] Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant
Villas-Boas, Lucy Santos
de Paula, Anderson Vicente
da Silva, Almir Ribeiro
Oliveira Paiao, Heuder Gustavo
Tozetto-Mendoza, Tania Regina
Manuli, Erika Regina
Leal, Fabio Eudes
Coscelli Ferraz, Andrea de Barros
Sabino, Ester Cerdeira
Bierrenbach, Ana Luiza
Witkin, Steven Sol
Mendes-Correa, Maria Cassia
CLINICS, 2022, 77
[5] Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2
Yu, Peng
Ran, Jingping
Yang, Ruiqi
Zhu, Hang
Lu, Song
Wu, Yuzhang
Zhao, Tingting
Xiong, Tianchen
FRONTIERS IN IMMUNOLOGY, 2024, 15
[6] The Contagious Nature of SARS-CoV-2 Omicron Variant and Vaccine Efficacy
Khan, Shahab Ahmad
Ahmad, Ijaz
Khan, Wajid
Khan, Hayat
Akbar, Sadiq
Akbar, Sadiq
ADVANCEMENTS IN LIFE SCIENCES, 2022, 9 (04): : 429 - 436
[7] Neutralizing and enhancing antibodies against SARS-CoV-2
Liu, Yafei
Arase, Hisashi
INFLAMMATION AND REGENERATION, 2022, 42 (01)
[8] Neutralizing and enhancing antibodies against SARS-CoV-2
Yafei Liu
Hisashi Arase
Inflammation and Regeneration, 42
[9] The wave of the SARS-CoV-2 Omicron variant resulted in a rapid spike and decline as highlighted by municipal wastewater surveillance
Cutrupi, Francesca
Cadonna, Maria
Manara, Serena
Postinghel, Mattia
La Rosa, Giuseppina
Suffredini, Elisabetta
Foladori, Paola
ENVIRONMENTAL TECHNOLOGY & INNOVATION, 2022, 28
[10] Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
da Silva, Almir Ribeiro, Jr.
Villas-Boas, Lucy Santos
Tozetto-Mendoza, Tania Regina
Honorato, Layla
de Paula, Anderson
Witkin, Steven S.
Mendes-Correa, Maria Cassia
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2022, 64

← 1 2 3 4 5 →